BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455-6; discussion 457. [PMID: 18400064 DOI: 10.1111/j.1600-0625.2008.00712_1.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 114] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Kamp S, Fiehn A, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam T, Jemec G. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa: Hidradenitis suppurativa: a disease of the absent sebaceous gland? British Journal of Dermatology 2011;164:1017-22. [DOI: 10.1111/j.1365-2133.2011.10224.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 7.2] [Reference Citation Analysis]
2 Wortsman X, Carreño L, Ferreira‐wortsman C, Poniachik R, Pizarro K, Morales C, Calderon P, Castro A. Ultrasound Characteristics of the Hair Follicles and Tracts, Sebaceous Glands, Montgomery Glands, Apocrine Glands, and Arrector Pili Muscles. J Ultrasound Med 2019;38:1995-2004. [DOI: 10.1002/jum.14888] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
3 Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB. Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials. Br J Dermatol 2019;181:967-75. [PMID: 30916379 DOI: 10.1111/bjd.17919] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
4 Rondags A, van Straalen KR, van Hasselt JR, Janse IC, Ardon CB, Vossen ARJV, Prens EP, van der Zee HH, Horváth B. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment. Br J Dermatol 2019;180:1214-20. [PMID: 30512186 DOI: 10.1111/bjd.17508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
5 Bechara FG, Sand M, Skrygan M, Kreuter A, Altmeyer P, Gambichler T. Acne inversa: evaluating antimicrobial peptides and proteins. Ann Dermatol 2012;24:393-7. [PMID: 23197903 DOI: 10.5021/ad.2012.24.4.393] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
6 Lousada M, Lachnit T, Edelkamp J, Rouillé T, Ajdic D, Uchida Y, Di Nardo A, Bosch T, Paus R. Exploring the human hair follicle microbiome*. Br J Dermatol 2021;184:802-15. [DOI: 10.1111/bjd.19461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 15.0] [Reference Citation Analysis]
7 Cuenca-Barrales C, Molina-Leyva A. Sexuality in Patients with Hidradenitis Suppurativa: Beliefs, Behaviors and Needs. Int J Environ Res Public Health 2020;17:E8808. [PMID: 33260862 DOI: 10.3390/ijerph17238808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Guet-Revillet H, Coignard-Biehler H, Jais JP, Quesne G, Frapy E, Poirée S, Le Guern AS, Le Flèche-Matéos A, Hovnanian A, Consigny PH. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20:1990-1998. [PMID: 25418454 DOI: 10.3201/eid2012.140064] [Cited by in Crossref: 75] [Cited by in F6Publishing: 55] [Article Influence: 15.0] [Reference Citation Analysis]
9 Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. ScientificWorldJournal 2015;2015:479354. [PMID: 25977937 DOI: 10.1155/2015/479354] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
10 Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, Boer J. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2013;27:473-8. [PMID: 22339940 DOI: 10.1111/j.1468-3083.2012.04468.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 111] [Article Influence: 14.3] [Reference Citation Analysis]
11 Gulliver W, Jemec G, Baker K. Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa: Ustekinumab in Hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology 2012;26:911-4. [DOI: 10.1111/j.1468-3083.2011.04123.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
12 Zouboulis CC. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa. Expert Review of Clinical Immunology 2016;12:1015-26. [DOI: 10.1080/1744666x.2016.1221762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Svensson A, Manolache L, Tzellos T, Sampogna F, Pustisek N, van der Zee HH, Marron SE, Spillekom-van Koulil S, Bewley A, Linder D, Abeni D, Szepietowski JC, Augustin M, Finlay AY. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol 2019;33:1633-43. [PMID: 31037773 DOI: 10.1111/jdv.15519] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
14 Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol 2019;28:94-103. [PMID: 30484907 DOI: 10.1111/exd.13849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ovadja ZN, Schuit MM, van der Horst CMAM, Lapid O. Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa. Br J Dermatol 2019;181:344-9. [PMID: 30585304 DOI: 10.1111/bjd.17588] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Theut Riis P, Pedersen OB, Sigsgaard V, Erikstrup C, Paarup HM, Nielsen KR, Burgdorf KS, Hjalgrim H, Rostgaard K, Banasik K, Ullum H, Jemec GB. Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study. Br J Dermatol 2019;180:774-81. [PMID: 29999187 DOI: 10.1111/bjd.16998] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
17 Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: A review of the literature. Int J Womens Dermatol 2019;5:330-4. [PMID: 31909152 DOI: 10.1016/j.ijwd.2019.06.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
18 Laffert MV, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis*: Bi-located inflammtion in HS. Experimental Dermatology 2010;19:533-7. [DOI: 10.1111/j.1600-0625.2009.00915.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 9.7] [Reference Citation Analysis]
19 de Haan JB, Hernandez N, Sen S. Erector spinae block for postoperative analgesia following axillary hidradenitis suppurativa resection: a case report. Local Reg Anesth 2018;11:87-90. [PMID: 30532584 DOI: 10.2147/LRA.S179830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 2012;7:e31810. [PMID: 22359634 DOI: 10.1371/journal.pone.0031810] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 13.4] [Reference Citation Analysis]
21 Morita A, Takahashi H, Ozawa K, Imafuku S, Nakama T, Takahashi K, Matsuyama T, Okubo Y, Kitamura S, Matsuda N, Zhao Y, Yokoyama M, Hayashi N, Terui T. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. J Dermatol 2019;46:745-51. [PMID: 31282051 DOI: 10.1111/1346-8138.14997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
22 Yazdanyar S, Jemec GB. Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis. 2011;24:118-123. [PMID: 21192260 DOI: 10.1097/qco.0b013e3283428d07] [Cited by in Crossref: 51] [Cited by in F6Publishing: 10] [Article Influence: 5.1] [Reference Citation Analysis]
23 Cuenca‐barrales C, Montero‐vílchez T, Szepietowski J, Matusiak L, Molina‐leyva A. Sexual impairment in patients with hidradenitis suppurativa: a systematic review. J Eur Acad Dermatol Venereol 2021;35:345-52. [DOI: 10.1111/jdv.16726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
24 Kirsten N, Frings V, Nikolakis GD, Presser D, Goebeler M, Zouboulis CC, Augustin M. [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:651-7. [PMID: 34223939 DOI: 10.1007/s00105-021-04851-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis. Front Immunol 2019;10:892. [PMID: 31105704 DOI: 10.3389/fimmu.2019.00892] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
26 Smith HS, Chao JD, Teitelbaum J. Painful Hidradenitis Suppurativa. The Clinical Journal of Pain 2010;26:435-44. [DOI: 10.1097/ajp.0b013e3181ceb80c] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
27 Vaienti S, Nazzaro G, Grancini A, Calzari P, Zaccaria G, Veraldi S, Vaienti L. Lymph Node Involvement in Axillary Hidradenitis Suppurativa: A Clinical, Ultrasonographic and Bacteriological Study Conducted during Radical Surgery. J Clin Med 2021;10:1433. [PMID: 33916058 DOI: 10.3390/jcm10071433] [Reference Citation Analysis]
28 Jung JM, Lee KH, Kim YJ, Chang SE, Lee MW, Choi JH, Won CH, Lee WJ. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa. JAMA Dermatol 2020;156:844-53. [PMID: 32459291 DOI: 10.1001/jamadermatol.2020.1422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
29 Turcu G, Ioana Nedelcu R, Teodora Nedelcu I, Hodorogea A, Balaban M, Brinzea A, Nichita L, Gabriela Popp C, Andrada Zurac S, Theodor Andrei R. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion. Exp Ther Med 2020;20:38-41. [PMID: 32508990 DOI: 10.3892/etm.2019.8150] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gotesman RD, Choi C, Alavi A. Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis. Int J Dermatol 2021. [PMID: 34075575 DOI: 10.1111/ijd.15671] [Reference Citation Analysis]
31 Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017;177:1401-9. [PMID: 28636793 DOI: 10.1111/bjd.15748] [Cited by in Crossref: 117] [Cited by in F6Publishing: 86] [Article Influence: 29.3] [Reference Citation Analysis]
32 Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin 2016;34:7-16. [PMID: 26617352 DOI: 10.1016/j.det.2015.08.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
33 van Rappard DC, Mekkes JR, Tzellos T. Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa. Dermatologic Clinics 2016;34:69-80. [DOI: 10.1016/j.det.2015.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
34 Fismen S, Ingvarsson G, Moseng D, Nathalie Dufour D, Jørgensen L. A clinical-pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two: HIDRADENITIS SUPPURATIVA - TWO DISEASES. APMIS 2012;120:433-40. [DOI: 10.1111/j.1600-0463.2011.02771.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
35 Happle R, König A. Smoker’s Boils. Dermatology 2011;222:282-4. [DOI: 10.1159/000327923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
36 Ruggiero A, Fabbrocini G, Megna M, Monfrecola G, Marasca C. Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS. Skin Appendage Disord 2020;6:366-9. [PMID: 33313053 DOI: 10.1159/000508669] [Reference Citation Analysis]
37 Katoulis AC, Liakou AI, Rotsiamis N, Bonovas S, Bozi E, Rallis E, Christodoulou C, Rigopoulos D. Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases. Skin Appendage Disord 2017;3:197-201. [PMID: 29177148 DOI: 10.1159/000475822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
38 Nikolakis G, Kokolakis G, Kaleta K, Wolk K, Hunger R, Sabat R, Zouboulis CC. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:658-65. [PMID: 34228138 DOI: 10.1007/s00105-021-04853-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dahmen RA, Lautenschlager S. [CME Dermatology 23: Hidradenitis suppurativa]. Praxis (Bern 1994) 2021;110:363-72. [PMID: 34019444 DOI: 10.1024/1661-8157/a003693] [Reference Citation Analysis]
40 Jemec GB. Hidradenitis suppurativa and immune dysregulation. Br J Dermatol 2012;166:237-8. [PMID: 22268854 DOI: 10.1111/j.1365-2133.2012.10802.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
41 Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28:779-793. [PMID: 20883920 DOI: 10.1016/j.det.2010.07.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
42 Kromann C, Deckers I, Esmann S, Boer J, Prens E, Jemec G. Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study. Br J Dermatol 2014;171:819-24. [DOI: 10.1111/bjd.13090] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 11.9] [Reference Citation Analysis]
43 Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2009;23:985-98. [PMID: 19682181 DOI: 10.1111/j.1468-3083.2009.03356.x] [Cited by in Crossref: 215] [Cited by in F6Publishing: 158] [Article Influence: 17.9] [Reference Citation Analysis]
44 Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N, Fabbrocini G, Monfrecola G. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol 2017;10:105-15. [PMID: 28458570 DOI: 10.2147/CCID.S111019] [Cited by in Crossref: 80] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
45 Jemec G. Predicting response to anti- TNF -alpha treatment in Hidradenitis suppurativa. British Journal of Dermatology 2013;168:233-233. [DOI: 10.1111/bjd.12192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Sellheyer K, Krahl D. What causes acne inversa (or hidradenitis suppurativa)?--the debate continues. J Cutan Pathol 2008;35:795-7. [PMID: 18687077 DOI: 10.1111/j.1600-0560.2008.01108.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Pelekanou A, Kanni T, Savva A, Mouktaroudi M, Raftogiannis M, Kotsaki A, Giamarellos-Bourboulis EJ. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial. Exp Dermatol. 2010;19:538-540. [PMID: 19758320 DOI: 10.1111/j.1600-0625.2009.00967.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
48 Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 2016;22:4802-11. [PMID: 27239107 DOI: 10.3748/wjg.v22.i20.4802] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
49 Kirschke J, Hessam S, Bechara F. Hidradenitis suppurativa/Acne inversa: Ein Update. Hautarzt 2015;66:413-22. [DOI: 10.1007/s00105-015-3616-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
50 Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur J Pharmacol. 2011;672:1-8. [PMID: 21930119 DOI: 10.1016/j.ejphar.2011.08.047] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
51 Alhusayen R, Shear NH. Pharmacologic Interventions for Hidradenitis Suppurativa: What Does the Evidence Say? American Journal of Clinical Dermatology 2012;13:283-91. [DOI: 10.2165/11631880-000000000-00000] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
52 van der Zee HH, de Ruiter L, Boer J, van den Broecke DG, den Hollander JC, Laman JD, Prens EP. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol 2012;166:98-106. [PMID: 21929531 DOI: 10.1111/j.1365-2133.2011.10643.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 8.5] [Reference Citation Analysis]
53 Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A. Bacteriology of hidradenitis suppurativa/acne inversa: A review. J Am Acad Dermatol 2015;73:S12-8. [PMID: 26470608 DOI: 10.1016/j.jaad.2015.07.041] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
54 Wortsman X, Moreno C, Soto R, Arellano J, Pezo C, Wortsman J. Ultrasound in-depth characterization and staging of hidradenitis suppurativa. Dermatol Surg 2013;39:1835-42. [PMID: 24118433 DOI: 10.1111/dsu.12329] [Cited by in Crossref: 88] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
55 Danby FW. Commentary: unroofing for hidradenitis suppurativa, why and how. J Am Acad Dermatol 2010;63:481.e1-3. [PMID: 20708473 DOI: 10.1016/j.jaad.2010.01.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
56 Fisher S, Jehassi A, Ziv M. Hidradenitis suppurativa on Facebook: thematic and content analyses of patient support group. Arch Dermatol Res 2020;312:421-6. [PMID: 31845011 DOI: 10.1007/s00403-019-02027-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 van der Zee HH, Laman JD, Prens EP. Can animal skin diseases or current transgenic mice serve as a model for hidradenitis suppurativa? Dermatology 2012;225:9-13. [PMID: 22907050 DOI: 10.1159/000339773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9-16. [PMID: 21547142 DOI: 10.4161/derm.2.1.12490] [Cited by in Crossref: 121] [Cited by in F6Publishing: 91] [Article Influence: 12.1] [Reference Citation Analysis]
59 Delany E, Gormley G, Hughes R, McCarthy S, Kirthi S, Markham T, Tobin AM, Murphy M, Kirby B. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32:467-473. [PMID: 29125658 DOI: 10.1111/jdv.14686] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
60 Fenini G, Contassot E, French LE. Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases. Front Pharmacol 2017;8:278. [PMID: 28588486 DOI: 10.3389/fphar.2017.00278] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
61 Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases. J Dermatol 2019;46:802-7. [PMID: 31271451 DOI: 10.1111/1346-8138.14998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
62 Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review. Skin Appendage Disord 2017;3:95-110. [PMID: 28560220 DOI: 10.1159/000462979] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
63 Shibuya Y, Morioka D, Nomura M, Zhang Z, Utsunomiya H. Earwax of patients with hidradenitis suppurativa: A retrospective study. Arch Plast Surg 2019;46:566-71. [PMID: 31775210 DOI: 10.5999/aps.2019.00290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Dunstan RW, Salte KM, Todorović V, Lowe M, Wetter JB, Harms PW, Burney RE, Scott VE, Smith KM, Rosenblum MD, Gudjonsson JE, Honore P. Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention. Exp Dermatol 2021;30:820-30. [PMID: 33377546 DOI: 10.1111/exd.14273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
65 Zhang M, Chen QD, Xu HX, Xu YM, Chen HJ, Yang BL. Association of hidradenitis suppurativa with Crohn's disease. World J Clin Cases 2021;9:3506-16. [PMID: 34046451 DOI: 10.12998/wjcc.v9.i15.3506] [Reference Citation Analysis]
66 Hessam S, Sand M, Skrygan M, Gambichler T, Bechara FG. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. Inflammation 2017;40:464-72. [PMID: 28028756 DOI: 10.1007/s10753-016-0492-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
67 Matusiak Ł, Bieniek A, Szepietowski JC. Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers 2009;14:432-7. [DOI: 10.1080/13547500903075218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
68 Tzellos T, Zouboulis C, Gulliver W, Cohen A, Wolkenstein P, Jemec G. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol 2015;173:1142-55. [DOI: 10.1111/bjd.14024] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 12.3] [Reference Citation Analysis]
69 Böhm M, Paus R. Towards a renaissance of dermatoendocrinology: Selected current frontiers. Exp Dermatol 2020;29:786-9. [PMID: 33319935 DOI: 10.1111/exd.14177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Richette P, Molto A, Viguier M, Dawidowicz K, Hayem G, Nassif A, Wendling D, Aubin F, Lioté F, Bachelez H. Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study. J Rheumatol 2014;41:490-4. [PMID: 24429166 DOI: 10.3899/jrheum.130977] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 8.9] [Reference Citation Analysis]
71 Cao Y, Hong F, Conlon DM, Sidur L, Smith KM, Fang Y, Cuff CA, Kaymakcalan Z, Ruzek MC. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol 2021. [PMID: 33811319 DOI: 10.1111/bjd.20097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
72 Deckers IE, van der Zee HH, Prens EP. Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS. Curr Derm Rep 2014;3:54-60. [DOI: 10.1007/s13671-013-0064-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
73 Lee A, Fischer G. A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol 2015;56:192-6. [PMID: 26080895 DOI: 10.1111/ajd.12362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
74 Giatrakos S, Huse K, Kanni T, Tzanetakou V, Kramer M, Grech I, Papadavid E, Katoulis A, Stavrianeas N, Nothnagel M, Platzer M, Bauer M, Giamarellos-bourboulis EJ. Haplotypes of IL-12Rβ1 impact on the clinical phenotype of hidradenitis suppurativa. Cytokine 2013;62:297-301. [DOI: 10.1016/j.cyto.2013.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
75 Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol 2009;18:833-41. [PMID: 19709092 DOI: 10.1111/j.1600-0625.2009.00924.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
76 Lukowsky A, Sterry W, Schneider-burrus S. Prevalence of the MspI and Ile462Val SNPs of Cytochrome P-450 1A1 in Hidradenitis Suppurativa: Letter to the Editor. Experimental Dermatology 2010;19:541-2. [DOI: 10.1111/j.1600-0625.2009.01058.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
77 Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17:343-351. [PMID: 26831295 DOI: 10.1007/s11154-016-9328-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 54] [Article Influence: 22.3] [Reference Citation Analysis]
78 Kelly G, Prens EP. Inflammatory Mechanisms in Hidradenitis Suppurativa. Dermatol Clin 2016;34:51-8. [PMID: 26617358 DOI: 10.1016/j.det.2015.08.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 7.6] [Reference Citation Analysis]
79 Hessam S, Sand M, Skrygan M, Bechara FG. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions. Arch Dermatol Res 2017;309:557-65. [DOI: 10.1007/s00403-017-1752-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Boer J, Nazary M, Riis PT. The Role of Mechanical Stress in Hidradenitis Suppurativa. Dermatologic Clinics 2016;34:37-43. [DOI: 10.1016/j.det.2015.08.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
81 Nikolakis G, Karagiannidis I, Vaiopoulos AG, Becker M, Zouboulis CC. Endokrine Mechanismen bei der Pathophysiologie der Hidradenitis suppurativa. Hautarzt 2020;71:762-71. [DOI: 10.1007/s00105-020-04679-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
82 DeFazio MV, Economides JM, King KS, Han KD, Shanmugam VK, Attinger CE, Evans KK. Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa. Ann Plast Surg. 2016;77:217-222. [PMID: 26559649 DOI: 10.1097/sap.0000000000000584] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
83 van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010;63:475-80. [PMID: 20708472 DOI: 10.1016/j.jaad.2009.12.018] [Cited by in Crossref: 99] [Cited by in F6Publishing: 62] [Article Influence: 9.0] [Reference Citation Analysis]
84 Revuz J. Hidradenitis suppurativa. La Presse Médicale 2010;39:1254-64. [DOI: 10.1016/j.lpm.2010.08.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
85 Ring HC, Riis Mikkelsen P, Miller IM, Jenssen H, Fuursted K, Saunte DM, Jemec GB. The bacteriology of hidradenitis suppurativa: a systematic review. Exp Dermatol. 2015;24:727-731. [PMID: 26119625 DOI: 10.1111/exd.12793] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
86 Mozeika E, Jemec GBE, Nürnberg BM. Hedgehog pathway does not play a role in hidradenitis suppurativa pathogenesis: Letter to the Editor. Experimental Dermatology 2011;20:841-2. [DOI: 10.1111/j.1600-0625.2011.01344.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
87 Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013;22:172-177. [PMID: 23489419 DOI: 10.1111/exd.12098] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
88 Al-Ali FM, Ratnamala U, Mehta TY, Naveed M, Al-Ali MT, Al-Khaja N, Sheth JJ, Master DC, Maiti AK, Chetan GK. Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region. Exp Dermatol. 2010;19:851-853. [PMID: 20698881 DOI: 10.1111/j.1600-0625.2010.01088.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
89 Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol 2010;62:637-45. [PMID: 20227579 DOI: 10.1016/j.jaad.2009.07.048] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
90 Grimstad Ø, Tzellos T, Dufour DN, Bremnes Ø, Skoie IM, Snekvik I, Jarnaess E, Kyrgidis A, Ingvarsson G. Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG). J Eur Acad Dermatol Venereol 2019;33:1164-71. [PMID: 30451320 DOI: 10.1111/jdv.15353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
91 Bechara FG, Hartschuh W. [Acne inversa]. Hautarzt 2010;61:39-46. [PMID: 20012929 DOI: 10.1007/s00105-009-1813-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
92 Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol. 2011;165:391-398. [PMID: 21457202 DOI: 10.1111/j.1365-2133.2011.10339.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 91] [Article Influence: 11.6] [Reference Citation Analysis]
93 Morand M, Hatami A. Silver-coated textiles in hidradenitis suppurativa: A case report. SAGE Open Med Case Rep 2019;7:2050313X19845212. [PMID: 31080599 DOI: 10.1177/2050313X19845212] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J 2014;90:216-21; quiz 220. [PMID: 24567417 DOI: 10.1136/postgradmedj-2013-131994] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 9.1] [Reference Citation Analysis]
95 Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539-561; quiz 562-563. [PMID: 19293006 DOI: 10.1016/j.jaad.2008.11.911] [Cited by in Crossref: 359] [Cited by in F6Publishing: 240] [Article Influence: 29.9] [Reference Citation Analysis]
96 Alzaga Fernandez AG, Demirci H, Darnley-fisch DA, Steen DW. Interstitial Keratitis Secondary to Severe Hidradenitis Suppurativa: A Case Report and Literature Review. Cornea 2010;29:1189-91. [DOI: 10.1097/ico.0b013e3181d4fd5c] [Cited by in Crossref: 19] [Article Influence: 1.7] [Reference Citation Analysis]
97 Nicoli F, Balzani A, Lazzeri D, Gentile P, Chilgar RM, Di Pasquali C, Nicoli M, Bocchini I, Agovino A, Cervelli V. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J. 2015;12:338-343. [PMID: 23834343 DOI: 10.1111/iwj.12117] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
98 Vankeviciute RA, Polozovaite B, Trapikas J, Raudonis T, Grigaitiene J, Bylaite-Bucinskiene M. A 12-Year Experience of Hidradenitis Suppurativa Management. Adv Skin Wound Care 2019;32:1-7. [PMID: 30570558 DOI: 10.1097/01.ASW.0000549611.06727.52] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Obadia DL, Daxbacher ELR, Jeunon T, Gripp AC. Hidradenite supurativa tratada com infliximabe. An Bras Dermatol 2009;84:695-7. [DOI: 10.1590/s0365-05962009000600022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
100 Savage KT, Singh V, Patel ZS, Yannuzzi CA, McKenzie-Brown AM, Lowes MA, Orenstein LAV. Pain management in hidradenitis suppurativa and a proposed treatment algorithm. J Am Acad Dermatol 2021;85:187-99. [PMID: 32950543 DOI: 10.1016/j.jaad.2020.09.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
102 Jørgensen A, Yao Y, Ghazanfar M, Ring H, Thomsen S. Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital‐based cohort study. J Eur Acad Dermatol Venereol 2019;34:565-73. [DOI: 10.1111/jdv.15904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
103 Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic Aspects of Hidradenitis Suppurativa. Dermatol Clin 2016;34:45-9. [PMID: 26617357 DOI: 10.1016/j.det.2015.08.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
104 Giamarellos-Bourboulis EJ, Bettoli V, Jemec GBE, Del Marmol V, Marzano AV, Prens EP, Tzellos T, Zouboulis CC. Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol 2021;30 Suppl 1:18-22. [PMID: 34085330 DOI: 10.1111/exd.14339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Mikkelsen PR, Jemec GB. Hidradenitis suppurativa in children and adolescents: a review of treatment options. Paediatr Drugs 2014;16:483-9. [PMID: 25234961 DOI: 10.1007/s40272-014-0091-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
106 Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis. Clin Exp Dermatol 2019;44:e126-32. [PMID: 30730068 DOI: 10.1111/ced.13922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
107 Jahns AC, Killasli H, Nosek D, Lundskog B, Lenngren A, Muratova Z, Emtestam L, Alexeyev OA. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS. 2014;122:804-809. [PMID: 24475943 DOI: 10.1111/apm.12220] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
108 O'Sullivan Coyne G, Woodring TS, Lee CR, Chen AP, Kong HH. Hidradenitis Suppurativa-Like Lesions Associated with Pharmacologic Inhibition of Gamma-Secretase. J Invest Dermatol 2018;138:979-81. [PMID: 29138057 DOI: 10.1016/j.jid.2017.09.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
109 Pektas SD, Cinar N, Duman DD, Kara A, Batu J, Karakas-Celik S, Aksoy DY. The relationship among androgens, insulin resistance and ghrelin polymorphisms in post-adolescent male patients with severe acne vulgaris. Postepy Dermatol Alergol 2020;37:800-9. [PMID: 33240024 DOI: 10.5114/ada.2020.100492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
110 Lasocki A, Sinclair R, Foley P, Saunders H. Hidradenitis suppurativa responding to treatment with infliximab: Hidradenitis suppurativa. Australasian Journal of Dermatology 2010;51:186-90. [DOI: 10.1111/j.1440-0960.2010.00623.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
111 Wormald JC, Balzano A, Clibbon JJ, Figus A. Surgical treatment of severe hidradenitis suppurativa of the axilla: Thoracodorsal artery perforator (TDAP) flap versus split skin graft. Journal of Plastic, Reconstructive & Aesthetic Surgery 2014;67:1118-24. [DOI: 10.1016/j.bjps.2014.04.032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
112 Emelianov V, Bechara F, Gläser R, Langan E, Taungjaruwinai W, Schröder J, Meyer K, Paus R. Immunohistological pointers to a possible role for excessive cathelicidin (LL‐37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. British Journal of Dermatology 2012;166:1023-34. [DOI: 10.1111/j.1365-2133.2011.10765.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 7.2] [Reference Citation Analysis]
113 Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 2012;166:879-83. [PMID: 22098253 DOI: 10.1111/j.1365-2133.2011.10747.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
114 Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 2016;17:335-41. [DOI: 10.1007/s11154-016-9366-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]